Depletion of circ_0007841 inhibits multiple myeloma development and BTZ resistance via miR-129-5p/JAG1 axis

References

• Palumbo A, Anderson K. Multiple myeloma. N Engl J Med. 2011;364(11):1046–1060.
   PubMed Web of Science ®Google Scholar
• Vrabel D, Pour L, Sevcikova S. The impact of NF-kappaB signaling on pathogenesis and current treatment strategies in multiple myeloma. Blood Rev. 2019;34:56–66.
   PubMed Web of Science ®Google Scholar
• Dimopoulos MA, Terpos E. Multiple myeloma. Ann Oncol. 2010;21(Suppl 7):vii143–150.
   PubMedGoogle Scholar
• Kehrer M, Koob S, Kehrer A, et al. Multiple Myeloma - Current Standards in Surgical Treatment. Z Orthop Unfall. 2019;157:164–172.
   PubMed Web of Science ®Google Scholar
• Landgren O, Iskander K. Modern multiple myeloma therapy: deep, sustained treatment response and good clinical outcomes. J Intern Med. 2017;281:365–382.
   PubMed Web of Science ®Google Scholar
• Shang Q, Yang Z, Jia R, et al. The novel roles of circRNAs in human cancer. Mol Cancer. 2019;18:6.
   PubMed Web of Science ®Google Scholar
• Chen B, Huang S. Circular RNA: an emerging non-coding RNA as a regulator and biomarker in cancer. Cancer Lett. 2018;418:41–50.
   PubMed Web of Science ®Google Scholar
• Nie WB, Zhao LM, Guo R, et al. Circular RNA circ-NT5C2 acts as a potential novel biomarker for prognosis of osteosarcoma. Eur Rev Med Pharmacol Sci. 2018;22:6239–6244.
   PubMed Web of Science ®Google Scholar
• Kun-Peng Z, Chun-Lin Z, Jian-Ping H, et al. A novel circulating hsa_circ_0081001 act as a potential biomarker for diagnosis and prognosis of osteosarcoma. Int J Biol Sci. 2018;14:1513–1520.
   PubMed Web of Science ®Google Scholar
• Liu X, Tang H, Liu J, et al. hsa_circRNA_101237: A Novel Diagnostic and Prognostic Biomarker and Potential Therapeutic Target for Multiple Myeloma. Cancer Manag Res. 2020;12:2109–2118.
   PubMed Web of Science ®Google Scholar
• Xu Z, Yan Y, Zeng S, et al. Circular RNAs: clinical relevance in cancer. Oncotarget. 2018;9:1444–1460.
   PubMedGoogle Scholar
• Feng Y, Zhang L, Wu J, et al. CircRNA circ_0000190 inhibits the progression of multiple myeloma through modulating miR-767-5p/MAPK4 pathway. J Exp Clin Cancer Res. 2019;38:54.
   PubMed Web of Science ®Google Scholar
• Gao M, Li C, Xiao H, et al. hsa_circ_0007841: A Novel Potential Biomarker and Drug Resistance for Multiple Myeloma. Front Oncol. 2019;9:1261.
   PubMed Web of Science ®Google Scholar
• Jansson MD, Lund AH. MicroRNA and cancer. Mol Oncol. 2012;6:590–610.
   PubMed Web of Science ®Google Scholar
• Xu YY, Song YQ, Huang ZM, et al. MicroRNA-26a inhibits multiple myeloma cell growth by suppressing cyclin-dependent kinase 6 expression. Kaohsiung J Med Sci. 2019;35:277–283.
   PubMed Web of Science ®Google Scholar
• Xu K, Hu X, Sun L, et al. MicroRNA-532 exerts oncogenic functions in t(4;14) multiple myeloma by targeting CAMK2N1. Hum Cell. 2019;32:529–539.
   PubMed Web of Science ®Google Scholar
• Yang Y, Li F, Saha MN, et al. miR-137 and miR-197 Induce Apoptosis and Suppress Tumorigenicity by Targeting MCL-1 in Multiple Myeloma. Clin Cancer Res. 2015;21:2399–2411.
   PubMed Web of Science ®Google Scholar
• Caracciolo D, Montesano M, Altomare E, et al. The potential role of miRNAs in multiple myeloma therapy. Expert Rev Hematol. 2018;11:793–803.
   PubMed Web of Science ®Google Scholar
• Shen X, Kong S, Yang Q, et al. PCAT-1 promotes cell growth by sponging miR-129 via MAP3K7/NF-κB pathway in multiple myeloma. J Cell Mol Med. 2020;24:3492–3503.
   PubMed Web of Science ®Google Scholar
• Grochowski CM, Loomes KM, Spinner NB. Jagged1 (JAG1): structure, expression, and disease associations. Gene. 2016;576:381–384.
   PubMed Web of Science ®Google Scholar
• Reedijk M, Odorcic S, Chang L, et al. High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival. Cancer Res. 2005;65:8530–8537.
   PubMed Web of Science ®Google Scholar
• Simon DP, Giordano TJ, Hammer GD. Upregulated JAG1 enhances cell proliferation in adrenocortical carcinoma. Clin Cancer Res. 2012;18:2452–2464.
   PubMed Web of Science ®Google Scholar
• Muguruma Y, Yahata T, Warita T, et al. Jagged1-induced Notch activation contributes to the acquisition of bortezomib resistance in myeloma cells. Blood Cancer J. 2017;7:650.
   PubMed Web of Science ®Google Scholar
• Rajkumar SV. Updated Diagnostic Criteria and Staging System for Multiple Myeloma. Am Soc Clin Oncol Educ Book. 2016;35:e418–423.
   PubMedGoogle Scholar
• Kunacheewa C, Orlowski RZ. New Drugs in Multiple Myeloma. Annu Rev Med. 2019;70:521–547.
   PubMed Web of Science ®Google Scholar
• Suzuki H, Zuo Y, Wang J, et al. Characterization of RNase R-digested cellular RNA source that consists of lariat and circular RNAs from pre-mRNA splicing. Nucleic Acids Res. 2006;34:e63.
   PubMed Web of Science ®Google Scholar
• Harland R, Misher L. Stability of RNA in developing Xenopus embryos and identification of a destabilizing sequence in TFIIIA messenger RNA. Development. 1988;102:837–852.
   PubMed Web of Science ®Google Scholar
• Ji T, Chen Q, Tao S, et al. The research progress of circular RNAs in hematological malignancies. Hematology. 2019;24:727–731.
   PubMed Web of Science ®Google Scholar
• Perez de Acha O, Rossi M, Gorospe M. Circular RNAs in Blood Malignancies. Front Mol Biosci. 2020;7:109.
   PubMed Web of Science ®Google Scholar
• Zhou F, Wang D, Wei W, et al. Comprehensive profiling of circular RNA expressions reveals potential diagnostic and prognostic biomarkers in multiple myeloma. BMC Cancer. 2020;20:40.
   PubMed Web of Science ®Google Scholar
• Wang Y, Lin Q, Song C, et al. Circ_0007841 promotes the progression of multiple myeloma through targeting miR-338-3p/BRD4 signaling cascade. Cancer Cell Int. 2020;20:383.
   PubMed Web of Science ®Google Scholar
• Song Y, Hu N, Song X, et al. Hsa_Circ_0007841 Enhances Multiple Myeloma Chemotherapy Resistance Through Upregulating ABCG2. Technol Cancer Res Treat. 2020;19:1533033820928371.
   Web of Science ®Google Scholar
• Thomas LF, Sætrom P. Circular RNAs are depleted of polymorphisms at microRNA binding sites. Bioinformatics. 2014;30:2243–2246.
   PubMed Web of Science ®Google Scholar
• Hansen TB, Jensen TI, Clausen BH, et al. Natural RNA circles function as efficient microRNA sponges. Nature. 2013;495:384–388.
   PubMed Web of Science ®Google Scholar
• Raimondo S, Urzi O, Conigliaro A, et al. Extracellular Vesicle microRNAs Contribute to the Osteogenic Inhibition of Mesenchymal Stem Cells in Multiple Myeloma. Cancers (Basel). 2020;12:449.
   PubMed Web of Science ®Google Scholar
• Zeng A, Yin J, Li Y, et al. miR-129-5p targets Wnt5a to block PKC/ERK/NF-κB and JNK pathways in glioblastoma. Cell Death Dis. 2018;9:394.
   PubMed Web of Science ®Google Scholar
• Wu Q, Meng WY, Jie Y, et al. LncRNA MALAT1 induces colon cancer development by regulating miR-129-5p/HMGB1 axis. J Cell Physiol. 2018;233:6750–6757.
   PubMed Web of Science ®Google Scholar
• Shen Q, Jiang Y. LncRNA NNT-AS1 promotes the proliferation, and invasion of lung cancer cells via regulating miR-129-5p expression. Biomed Pharmacother. 2018;105:176–181.
   PubMed Web of Science ®Google Scholar
• Liu Q, Jiang J, Fu Y, et al. MiR-129-5p functions as a tumor suppressor in gastric cancer progression through targeting ADAM9. Biomed Pharmacother. 2018;105:420–427.
   PubMed Web of Science ®Google Scholar
• Zhang H, Cai Y, Zheng L, et al. Long noncoding RNA NEAT1 regulate papillary thyroid cancer progression by modulating miR-129-5p/KLK7 expression. J Cell Physiol. 2018;233:6638–6648.
   PubMed Web of Science ®Google Scholar
• Xin Z, Ma Q, Ren S, et al. The understanding of circular RNAs as special triggers in carcinogenesis. Brief Funct Genomics. 2017;16:80–86.
   PubMed Web of Science ®Google Scholar
• Jia CM, Tian YY, Quan LN, et al. miR-26b-5p suppresses proliferation and promotes apoptosis in multiple myeloma cells by targeting JAG1. Pathol Res Pract. 2018;214:1388–1394.
   PubMed Web of Science ®Google Scholar
• Donato L, D’Angelo R, Alibrandi S, et al. Effects of A2E-Induced Oxidative Stress on Retinal Epithelial Cells: new Insights on Differential Gene Response and Retinal Dystrophies. Antioxidants (Basel). 2020;9:307.
   PubMedGoogle Scholar
• Wan Y, Yang ZQ. LncRNA NEAT1 affects inflammatory response by targeting miR-129-5p and regulating Notch signaling pathway in epilepsy. Cell Cycle. 2020;19:419–431.
   PubMed Web of Science ®Google Scholar